Association of Different Combinations of ALDH2 rs671, APOE rs429358, rs7412 Polymorphisms with Hypertension in Middle-Aged and Elderly People: A Case-Control Study. 2023

Xinping Lan, and Zhenchang Wang, and Zifeng Zeng, and Huaqing Yao, and Weiyong Xu, and Yuxian Zhang
Center for Cardiovascular Diseases, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China.

Hypertensive patients have a younger trend, and studies on the role of genetic factors in hypertension susceptibility have been inconsistent. Aldehyde dehydrogenases 2 (ALDH2) and apolipoprotein E (APOE) are involved in the pathophysiological processes of hypertension. To investigate the relationship of ALDH2 and APOE polymorphisms with hypertension in middle-aged (30-59 years old) and elderly (≥60 years old) persons. Two thousand six hundred and ten hypertensive patients and 1921 controls were included (between 30 and 100 years old). The genotypes of common polymorphisms in APOE and ALDH2 genes (APOE rs429358, rs7412, and ALDH2 rs671) of the subjects were analyzed by polymerase-chain reaction (PCR)-microarray. Statistical analyses (Student's t-test, Mann-Whitney U-test, χ 2 test, and logistic regression analysis) were performed with SPSS v21.0. There were 4531 participants (66.60 ± 12.10 years old) in this study, including 3057 (67.5%) males and 1474 (32.5%) females. There were no significant differences in distributions of ALDH2 rs671, APOE rs429358/rs7412 genotypes and alleles between hypertensive patients and controls. Persons with ALDH2 rs671 G/A or A/A genotype were less likely to have hypertension (G/A+A/A vs G/G: gender-, age-, smoking-, and drinking-adjusted OR 0.885, 95% CI 0.785-0.997, P=0.045), while ALDH2 rs671 A/A+APOE rs429358 or rs7412 wild-type genotype may decrease the risk of hypertension. In middle-aged group, ALDH2 rs671 G/A+APOE rs429358 T/C carriers (adjusted OR 0.547, 95% CI 0.350-0.856, P=0.008), and ALDH2 rs671 A/A+APOE rs7412 C/C genotypes (adjusted OR 0.567, 95% CI 0.361-0.891, P=0.014) were less likely to have hypertension. In elderly group, APOE rs7412 T/T carriers were more likely to have hypertension (rs671 T/T vs C/C: adjusted OR 4.755, 95% CI 1.075-21.027, P=0.040; rs671 T/T vs C/C or C/T: adjusted OR 4.734, 95% CI 1.071-20.928, P=0.040). Polymorphism-polymorphism interactions of ALDH2 rs671 and APOE rs429358/rs7412 may effect on hypertension susceptibility. Different genotypes comparison shows different roles in middle-aged and elderly people, respectively.

UI MeSH Term Description Entries

Related Publications

Xinping Lan, and Zhenchang Wang, and Zifeng Zeng, and Huaqing Yao, and Weiyong Xu, and Yuxian Zhang
March 2022, BMC cardiovascular disorders,
Xinping Lan, and Zhenchang Wang, and Zifeng Zeng, and Huaqing Yao, and Weiyong Xu, and Yuxian Zhang
January 2017, PloS one,
Xinping Lan, and Zhenchang Wang, and Zifeng Zeng, and Huaqing Yao, and Weiyong Xu, and Yuxian Zhang
July 2023, Genes,
Xinping Lan, and Zhenchang Wang, and Zifeng Zeng, and Huaqing Yao, and Weiyong Xu, and Yuxian Zhang
January 2018, Folia biologica,
Xinping Lan, and Zhenchang Wang, and Zifeng Zeng, and Huaqing Yao, and Weiyong Xu, and Yuxian Zhang
January 2024, Biology,
Xinping Lan, and Zhenchang Wang, and Zifeng Zeng, and Huaqing Yao, and Weiyong Xu, and Yuxian Zhang
September 2017, Scientific reports,
Xinping Lan, and Zhenchang Wang, and Zifeng Zeng, and Huaqing Yao, and Weiyong Xu, and Yuxian Zhang
March 2020, Annals of translational medicine,
Xinping Lan, and Zhenchang Wang, and Zifeng Zeng, and Huaqing Yao, and Weiyong Xu, and Yuxian Zhang
January 2023, Environmental health and preventive medicine,
Xinping Lan, and Zhenchang Wang, and Zifeng Zeng, and Huaqing Yao, and Weiyong Xu, and Yuxian Zhang
March 2022, BMC psychiatry,
Xinping Lan, and Zhenchang Wang, and Zifeng Zeng, and Huaqing Yao, and Weiyong Xu, and Yuxian Zhang
March 2023, Genes,
Copied contents to your clipboard!